Salud financiera de hoja de balance de UpHealth

Salud financiera controles de criterios 0/6

UpHealth tiene un patrimonio de accionistas total de $55.1M y una deuda total de $147.5M, lo que sitúa su ratio deuda-patrimonio en 267.6%. Sus activos y pasivos totales son $231.8M y $176.7M respectivamente. El BAIT de UpHealth es de $4.9M, por lo que su ratio de cobertura de intereses es de 0.2. Tiene efectivo e inversiones a corto plazo que ascienden a $2.5M.

Información clave

267.6%

Ratio deuda-patrimonio

US$147.47m

Deuda

Ratio de cobertura de intereses	0.2x
Efectivo	US$2.55m
Patrimonio	US$55.10m
Total pasivo	US$176.70m
Activos totales	US$231.81m

Actualizaciones recientes sobre salud financiera

Recent updates

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($20.2M) de UPHL no cubren sus pasivos a corto plazo ($26.8M).

Pasivo a largo plazo: Los activos a corto plazo ($20.2M) de UPHL no cubren sus pasivos a largo plazo ($149.9M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de UPHL (263%) se considera alta.

Reducción de la deuda: No se dispone de datos suficientes para determinar si el ratio deuda-patrimonio de UPHL se ha reducido en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: UPHL tiene menos de un año de cash runway basado en su flujo de caja libre actual.

Pronóstico de cash runway: UPHL tiene menos de un año de cash runway si el flujo de caja libre sigue reduciéndose a tasas históricas de 2.7% cada año

Salud financiera de hoja de balance de UpHealth

Salud financiera controles de criterios 0/6

Información clave

Actualizaciones recientes sobre salud financiera

UpHealth, Inc. announced delayed annual 10-K filing

NYSE Grants UpHealth's Request for A Hearing Before the CFR

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

UpHealth, Inc. announced delayed 10-Q filing

UpHealth, Inc. announced delayed 10-Q filing

Recent updates

UpHealth, Inc. announced delayed annual 10-K filing

GTCR LLC completed the acquisition of Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH).

NYSE Grants UpHealth's Request for A Hearing Before the CFR

Uphealth, Inc. Elects James Greene as Director

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

NYSE Regulation Determines to Commence Proceedings to Delist the UpHealth's Common Stock

UpHealth, Inc., Annual General Meeting, Dec 27, 2023

UpHealth, Inc. Reports Impairment of Goodwill, Intangible Assets, and Other Long-Lived Assets for the Third Quarter Ended September 30, 2023

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

GTCR LLC entered into a membership interests purchase agreement to acquire Cloudbreak Health, LLC from UpHealth, Inc. (NYSE:UPH) for approximately $180 million.

UpHealth, Inc. announced delayed 10-Q filing

Uphealth, Inc. Announces CFO Changes

Uphealth, Inc. Announces Board Changes

UpHealth, Inc.(NYSE:UPH) dropped from S&P TMI Index

Price target increased by 11% to US$7.02

Consensus EPS estimates fall by 30%, revenue upgraded

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

UpHealth, Inc. Revises Earnings Guidance for the Year 2023

UpHealth, Inc. to Report Q2, 2023 Results on Aug 10, 2023

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

UpHealth, Inc. to Report Q1, 2023 Results on May 11, 2023

Full year 2022 earnings: EPS misses analyst expectations

Analysts Just Shaved Their UpHealth, Inc. (NYSE:UPH) Forecasts Dramatically

Consensus revenue estimates fall by 11%

Full year 2022 earnings: EPS misses analyst expectations

High number of new and inexperienced directors

UpHealth, Inc., Announces Resignation of Ramesh Balakrishnan as President and Chief Strategy Officer

UpHealth FQ3 revenue misses

UpHealth, Inc. Appoints Timothy Wilde as Chief Technology Officer

UpHealth says reverse stock split to effect changes to warrant terms

Uphealth, Inc. Announces Executive Appointments

UpHealth, Inc., Annual General Meeting, Dec 05, 2022

UpHealth, Inc. announced delayed 10-Q filing

Uphealth Inc. Announces Appointment of Melissa Frieswick, as Chief Growth Officer

Uphealth, Inc. Appoints Mahesh Inder Veer Singh as Executive Vice President

Consensus EPS estimates fall by 25%

UpHealth, Inc. announced that it has received $67.5 million in funding

UpHealth: The SPAC Disaster 'Du Jour'

Price target decreased to US$3.50

No longer forecast to breakeven

UpHealth Q2 2022 Earnings Preview

UpHealth Provides Information to Shareholders

UpHealth, Inc Announces Board Changes

UpHealth, Inc. Appoints Samuel J. Meckey as Chief Executive Officer

Jeffery Bray Provides Information to Shareholders of UpHealth Inc

Jeffery R. Bray Sends an Email to Shareholders of UpHealth

UpHealth Inc Communicates with Shareholders

UpHealth, Inc. Announces Board Changes

Mariya Pylypiv Discloses its Views on UpHealth

UpHealth, Inc. Appoints Daniel Mandoli as Executive Vice President of U.S. Services, Effective June 13, 2022

UpHealth: Troubled Virtual Healthcare Provider Still Searching For Answers

UpHealth Receives Non-Compliance Notice from NYSE

UpHealth, Inc. announced delayed 10-Q filing

UpHealth Announces Samuel J. Meckey as Chief Executive Officer, Effective July 2022

UpHealth, Inc. Provides Unaudited Earnings Guidance for the Year Ended December 31, 2022

UpHealth, Inc., Annual General Meeting, Jun 28, 2022

UpHealth, Inc. announced delayed annual 10-K filing

These Analysts Think UpHealth, Inc.'s (NYSE:UPH) Sales Are Under Threat

UpHealth, Inc. Provides Earnings Guidance for the Full Year 2022

UpHealth, Inc. Releases Martti™ Translation, Expanding Language Access Offering

UpHealth Is A Great Bargain At These Levels

Co-Founder recently bought US$102k worth of stock

Why UpHealth Has 300% Upside

Forecast to breakeven in 2023

UpHealth: Interesting But Difficult To Value

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Análisis de la situación financiera